Ani Pharmaceuticals (ANIP) Current Taxes (2013 - 2026)

Ani Pharmaceuticals (ANIP) has 13 years of Current Taxes data on file, last reported at $5.3 million in Q1 2026.

• For the quarter ending Q1 2026, Current Taxes fell 62.67% year-over-year to $5.3 million; the trailing twelve-month figure through Mar 2026 stood at $5.3 million (down 62.67% YoY), and the FY2025 full-year result was $2.2 million, down 60.17% from the prior year.
• Current Taxes rose to $5.3 million in Q1 2026, from $2.2 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $14.2 million in Q1 2025 to a low of $594000.0 in Q3 2023.
• A 4-year average of $6.4 million and a median of $5.5 million in 2024 frame the typical range for Current Taxes.
• Across the five-year window, Current Taxes grew 24.43% in 2025 and slumped 62.67% in 2026, its largest moves.
• Tracing ANIP's Current Taxes over 4 years: stood at $8.2 million in 2023, then plunged by 31.14% to $5.6 million in 2024, then plunged by 60.17% to $2.2 million in 2025, then surged by 136.58% to $5.3 million in 2026.
• Business Quant data shows ANIP's Current Taxes at $5.3 million in Q1 2026, $2.2 million in Q4 2025, and $3.3 million in Q2 2025.